Cafepharma Today

June 17 2021 - Valuations expected to fall in healthtech IPOs
Valuations expected to fall in healthtech IPOs
Novartis gets breakthrough designation with radiopharma acquisition
The big FDA approvals still in the cards for 2021
Blueprint Medicines gets fourth FDA drug approval
*please scroll down for all the latest news*

Stay updated with the latest pharma-related coronavirus news on our new page

Today's most popular searches:

Current News

submit a press release

Click here to stay updated on CP happenings
Bloom is off the health tech IPO rose, as valuations expected to fall
MedCity News
Thursday, June 17, 2021 - 12:16pm
tags:
IPOs, devices, digital health, healthtech, Medtech
Sanofi and Regeneron's high-flying Dupixent tops May pharma TV spending, trading places with AbbVie's Humira
Fierce Pharma
Thursday, June 17, 2021 - 12:12pm
tags:
Sanofi, Regeneron, Dupixent, DTC ads, television ads
Novartis sets the tone for the radiopharma push with a prized acquisition winning breakthrough therapy designation
Endpoints
Thursday, June 17, 2021 - 11:09am
tags:
Novartis, radiopharmaceuticals, breakthrough therapy, FDA, Lu-PSMA-617
Getting under your skin: Sorrento leveraging novel drug delivery platform to treat melanoma in tie-up with Mayo Clinic
BioPharma Dive
Thursday, June 17, 2021 - 11:06am
tags:
Sorrento Therapeutics, melanoma, R&D, Mayo Clinic
The big approvals still on the cards for 2021
EP Vantage
Thursday, June 17, 2021 - 11:00am
tags:
FDA, drug approvals, Argenx, Novartis, AstraZeneca, Astellas, UCB Pharma, Ascendis Pharma, ChemoCentryx, Axsome Therapeutics
Danaher to buy biotech company Aldevron for about $9.6 billion
Yahoo/Reuters
Thursday, June 17, 2021 - 10:58am
tags:
Danaher, Aldevron, devices, M&A
Thermo Fisher development solution offers timelines of 13 months to clinic
Biopharma Reporter
Thursday, June 17, 2021 - 10:57am
tags:
Thermo Fisher, clinical trials, drug development
Lilly helps Circle round up $66M for intractable target R&D
Fierce Biotech
Thursday, June 17, 2021 - 10:56am
tags:
Circle Pharma, cyclin, Eli Lilly, R&D, funding
Rare Blood Disease Drug Win Marks Fourth Approval for Blueprint Medicines
BioSpace
Thursday, June 17, 2021 - 10:55am
tags:
Blueprint Medicines, Ayvakit, MCL, systemic mastocytosis, FDA
In a move to boost its natural killer candidates, Senti Bio will build out its own San Francisco manufacturing facility
Endpoints
Thursday, June 17, 2021 - 10:51am
tags:
Senti Biosciences, natural killer cells, drug manufacturing
This Biopharma Giant May Have Just Found Its Ticket To Riches In the COVID-19 Market
Motley Fool
Thursday, June 17, 2021 - 10:50am
tags:
Merck, Ridgeback Biotherapeutics, COVID-19, molnupiravir, antivirals
First patient receives controversial Biogen Alzheimer's drug
NASDAQ
Wednesday, June 16, 2021 - 11:40pm
tags:
Biogen, Aduhelm, Alzheimer's disease
Express Scripts urged to withdraw new 340B claims policy
Beckers Hospital Review
Wednesday, June 16, 2021 - 11:34pm
tags:
Express Scripts, 340B, American Hospital Association, PBMs
FDA authorizes more J&J vaccines made at Emergent plant
Beckers Hospital Review
Wednesday, June 16, 2021 - 11:31pm
tags:
FDA, vaccines, JNJ, Emergent BioSolutions
Biogen's other Alzheimer's drug fails in late-stage trial
Bizjournals
Wednesday, June 16, 2021 - 11:26pm
tags:
Biogen, Alzheimer's disease, clinical trials, gosuranemab
Privacy issues widespread with digital health apps, says BMJ
Pharmaforum
Wednesday, June 16, 2021 - 11:22pm
tags:
digital health, mobile apps, privacy
CureVac's first-gen COVID-19 vaccine misses the mark with 47% efficacy, as share price halves in after-hours trading
Fierce Biotech
Wednesday, June 16, 2021 - 11:21pm
tags:
CureVac, MRNA, vaccines, COVID-19
Why Kindred Biosciences Stock Skyrocketed Today
Motley Fool
Wednesday, June 16, 2021 - 11:19pm
tags:
Kindred Biosciences, M&A, animal health, Elanco Animal Health
MannKind and United Snag Priority Review for Pulmonary Hypertension Drug
BioSpace
Wednesday, June 16, 2021 - 11:17pm
tags:
MannKind, United Therapeutics, PAH, PH-ILD, FDA, priority review, Tyvaso
Public Citizen demands removal of top FDA officials over Biogen Alzheimer's approval
Seeking Alpha
Wednesday, June 16, 2021 - 11:58am
tags:
Biogen, FDA, Public Citizen, Aduhelm, Alzheimer's disease, Janet Woodcock

Pages

Latest CP Wire Articles

Sirona Biochem's Innovations in Biotechnology Lead to Safer, More Effective Cosmetic and Pharmaceutical Active Ingredients
Vaccinated? Don’t Let Your Guard Down Just Yet, says Ohio Math Expert
High School Student Calls On Pharmaceutical Industry To Fund The Planting of 1 Million Trees In 5 Years In National Forests To Increase HCP Access
5 Ways Telemedicine Is Helping Health Care Providers In 2021[sponsored]
“Special Fraud Alert” Targets Pharma & Medical Device Speaker Programs
Launch of Unprecedented Biotech Data Resource
Bigfinite is Now Aizon
SIFI reports positive results from 044/si phase 3 clinical trial further highlighting strength of its NETILDEX® franchise
Highlights: 2020 Cardiometabolic Health Congress West Live Online
Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections

Latest Pharmagather Articles

Chose Your Controls Wisely
In the Pipeline
EXCLUSIVE: The 340B Program Soared to $38 Billion in 2020—Up 27% vs. 2019
Drug Channels
The Novavax Vaccine Data, and Spike Proteins in General
In the Pipeline
Exclusive: 340B Continues Its Unbridled Takeover of Pharmacies and PBMs
Drug Channels
Informa Connect’s 18th Life Sciences Accounting & Reporting Congress
Drug Channels
The Top Five Considerations When Choosing a Patient Solutions Provider
Drug Channels
An Update on Global Availability of COVID-19 Vaccines from Editor of The Lancet
Elsevier
Days Off
In the Pipeline
The Aducanumab Approval
In the Pipeline

Pharma and Device News from NASDAQ

Intrommune Therapeutics to Present at BIO Digital 2021
Thursday, June 17, 2021 - 9:11am
Gevo hires Kimberly Bowron as Chief Human Resources Officer
Thursday, June 17, 2021 - 9:00am
Insights on the Microfluidics Global Market to 2029 - Key Drivers, Challenges and Opportunities
Thursday, June 17, 2021 - 8:33am
InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast featuring Tryp Therapeutics Inc. Chairman and CEO Greg McKee
Thursday, June 17, 2021 - 8:17am
Entera Bio Receives Foundational Patent for its Oral PTH using its Platform Oral Protein Delivery Technology in European Union
Thursday, June 17, 2021 - 8:00am
Onconova Therapeutics Announces the Peer-Reviewed Publication of Preclinical Data Demonstrating the Synergistic Anti-Cancer Activity of Rigosertib Combined with Immune Checkpoint Blockade
Thursday, June 17, 2021 - 8:00am
Global Global Blood Glucose Monitoring Devices Market (2021 to 2026) - by Product, End-user and Geography
Thursday, June 17, 2021 - 7:43am
Global Reaction Monitoring Market (2021 to 2026) - by Technology, Reaction Mode, End-user and Geography
Thursday, June 17, 2021 - 6:48am
The Oxygen Concentrators Global Market is Expected to Grow at a CAGR of 8.6% Between 2020 to 2026
Thursday, June 17, 2021 - 5:53am
Worldwide Massage Equipment Industry to 2026 - Flourishing Wellness Tourism Industry Presents Opportunities
Thursday, June 17, 2021 - 5:48am

Want to host your own webinar?

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information